ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,122Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 5176

$1.25M Total Retail Price of All Prescriptions

Rank: 158 out of 5176

599 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 16,455 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
ALENDRONATE SODIUM 1,343 1,230 1 18
SIMVASTATIN 946 829 2 1
AMLODIPINE BESYLATE 904 799 3 2
ATENOLOL 556 502 4 12
METFORMIN HCL 492 437 5 7
DIOVAN 490 464 6 19
LIDODERM 486 460 7 59
CRESTOR 425 386 8 15
EVISTA 354 342 9 65
OMEPRAZOLE 338 312 10 3
LOSARTAN POTASSIUM 326 303 11 14
GLIPIZIDE XL 277 251 12 83
TAMSULOSIN HCL 275 275 13 20
ATORVASTATIN CALCIUM 275 266 13 9
FINASTERIDE 268 265 15 69
AMMONIUM LACTATE 263 233 16 91
DIOVAN HCT 251 227 17 39
NEXIUM 248 210 18 16
MELOXICAM 246 218 19 53
JANUVIA 230 223 20 25
LOVAZA 217 195 21 43
IBUPROFEN 198 172 22 72
FLUTICASONE PROPIONATE 192 182 23 38
AZITHROMYCIN 191 170 24 42
GLYBURIDE-METFORMIN HCL 189 185 R 25 76
LIPITOR 169 162 26 51
LOSARTAN-HYDROCHLOROTHIAZIDE 163 140 27 35
GABAPENTIN 160 149 28 21
CLOTRIMAZOLE-BETAMETHASONE 160 141 28 94
HYDROCORTISONE VALERATE 151 132 30 319
MECLIZINE HCL 140 132 31 81
COLCRYS 137 120 32 170
METOPROLOL SUCCINATE 136 133 33 11
ENALAPRIL MALEATE 134 133 34 22
ALLOPURINOL 129 116 35 41
LEVOTHYROXINE SODIUM 127 125 36 4
CHLORHEXIDINE GLUCONATE 125 103 37 202
AMOXICILLIN 124 105 38 163
ACTOS 122 111 39 85
PLAVIX 121 121 40 29
HYDROCHLOROTHIAZIDE 118 112 41 10
DONEPEZIL HCL 116 116 42 28
LIDOCAINE 116 100 42 179
CLOPIDOGREL 116 116 42 26
VENTOLIN HFA 113 84 45 64
ADVAIR DISKUS 111 90 46 32
PATANOL 110 100 47 158
ZOLPIDEM TARTRATE 109 96 48 17
MUPIROCIN 109 95 48 182
PROAIR HFA 96 92 50 60
CLOBETASOL PROPIONATE 96 91 50 130
VOLTAREN 93 86 52 97
ATELVIA 93 88 52 146
TERAZOSIN HCL 91 91 54 158
METOPROLOL TARTRATE 90 79 55 6
FUROSEMIDE 90 81 55 8
CARVEDILOL 84 84 57 24
TRIAMCINOLONE ACETONIDE 80 79 58 125
LISINOPRIL 78 78 59 5
ACTONEL 75 66 60 134
NAMENDA 72 72 61 47
SINGULAIR 70 65 62 62
PROCTOZONE-HC 69 59 63 171
NIFEDIPINE ER 68 66 64 48
SPIRIVA 67 67 65 54
VERAPAMIL ER 65 65 66 155
SYNTHROID 64 58 67 33
CELEBREX 62 58 68 80
COMBIVENT 61 61 69 156
LACTULOSE 60 58 70 87
CICLOPIROX 60 41 70 279
FENOFIBRATE 57 49 72 102
LACLOTION 54 51 73 299
AZELASTINE HCL 52 48 74 267
POTASSIUM CHLORIDE 52 51 74 34
VALSARTAN-HYDROCHLOROTHIAZIDE 52 42 74 292
MICARDIS 51 51 77 154
CROMOLYN SODIUM 50 46 78 332
METHIMAZOLE 50 21 78 331
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.